Paper Details

  1. Home
  2. Paper Details

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.

Author: BalkEthan M, EarleyAmy K, SchmidChristopher H, UhligKatrin, WagnerMartin, WebsterAngela C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This research examines the comparative effects of azathioprine (AZA) and mycophenolic acid (MPA) for immunosuppression after kidney transplantation. MPA is often favored over AZA, but the study explores the trade-offs between effectiveness, cost, and other factors.
Paper Details　
Original Abstract of the Article :
Modern immunosuppressive regimens after kidney transplantation usually use a combination of two or three agents of different classes to prevent rejection and maintain graft function. Most frequently, calcineurin-inhibitors (CNI) are combined with corticosteroids and a proliferation-inhibitor, either...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD007746.pub2

データ提供：米国国立医学図書館（NLM）

Mycophenolic Acid vs. Azathioprine: A Showdown in the Desert of Immunosuppression

Kidney transplantation, a life-saving procedure, often involves a complex journey through the desert of immunosuppression. This research compares the effectiveness of two commonly used immunosuppressants, mycophenolic acid (MPA) and azathioprine (AZA), in preventing rejection and maintaining graft function. The authors meticulously analyze the evidence for each drug, seeking to identify the optimal approach for managing immunosuppression after transplantation.

Navigating the Landscape of Immunosuppression

The study, like a meticulous desert explorer charting the most efficient route, examines the relative merits of MPA and AZA. The researchers analyze clinical trials, considering factors such as immunosuppressive potency, cost-effectiveness, and potential side effects.

A Guide for Transplant Clinicians

The findings of this study provide valuable information for transplant clinicians, guiding them in choosing the most appropriate immunosuppressive regimen for their patients. The research offers a balanced perspective on the relative strengths and weaknesses of MPA and AZA, facilitating informed decision-making in this crucial area of transplant care.

Dr.Camel's Conclusion

This research, like a desert oasis offering multiple paths to a destination, highlights the need for personalized approaches to immunosuppression after kidney transplantation. The insights gained from this study can help clinicians tailor treatment strategies to maximize graft survival and minimize the risk of complications.
Date :
  1. Date Completed 2016-04-28
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

26633102

DOI: Digital Object Identifier

10.1002/14651858.CD007746.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.